Federico Ravaioli, Arthur Berger, Oana Farcau, Antonio Colecchia, Horia Stefanescu, Camille Candillier, Pierre Nahon, Christophe Bureau, Nathalie Ganne-Carriè, Annalisa Berzigotti, Victor de Ledinghen, Salvatore Petta, Paul Calès, Multicentric Groups, Bologna, Cluj, Bondy, Toulouse, Bern, Bordeaux, Palermo
BACKGROUND: Several tests have been developed to screen VNT in different screening settings. We aimed to develop simple estimators to quantify VNT risk and spare endoscopy while missing <5% of VNT, adapted to different screenings in the main etiologies. METHODS: 2,368 patients with chronic liver disease were included. The main VNT predictors were platelets, prothrombin index (PI) and LSM. Their interactions led to score construction, LIP: (LSM*45)/(PI*platelets), and BLIP: BMI-adjusted LIP in NAFLD...
April 13, 2023: Clinics and Research in Hepatology and Gastroenterology